Viewing nowCombinationEnblomet Extended-Release Tablet 0.3/1000 mg (Inavogliflozin, Metformin Hydrochloride)
Enavogliflozin 0.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 202301819 · Approved 2023.06.13 · Insurance code 641607880
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist patients with type 2 diabetes in controlling their blood glucose levels. When taken alongside dietary control and exercise, it helps to effectively lower blood sugar levels. Inavogliflozin and metformin work together to contribute to the improvement of blood sugar levels. It is recommended as an adjunct therapy when patients experience difficulties managing their blood sugar in daily life. It facilitates smooth blood glucose control through consistent use and lifestyle modifications.
This medicine is administered to patients receiving inavogliflozin 0.3 mg and extended-release metformin hydrochloride 1000 mg as 1 tablet once daily with a meal. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from another antihyperglycemic agent. Because changes in glycemic control may occur, any changes to treatment in patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole. Do not split, crush, grind, or chew it. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. No dose adjustment is needed in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73m2. This medicine should be discontinued if the estimated glomerular filtration rate (eGFR) remains below 60 mL/min/1.73m2.
This medication contains metformin hydrochloride and inavogliflozin, and is used for the treatment of diabetes. Caution is necessary as serious side effects such as lactic acidosis may occur when taking this medication. Lactic acidosis is a condition that occurs when there is an excessive accumulation of lactic acid in the body, which can be life-threatening in severe cases. Patients with significantly reduced kidney function, serious infection, dehydration, or acute heart failure should not use this medication. Additionally, patients with type 1 diabetes or a history of diabetic ketoacidosis should not use this medication. While taking this medication, fluid volume may decrease or kidney function may be affected, so elderly patients or those taking diuretics should regularly monitor their fluid status and kidney function. Moreover, this medication has blood sugar-lowering effects, thus irregular meals, intense exercise, or excessive alcohol consumption can increase the risk of hypoglycemia, necessitating caution. The inavogliflozin component of this medication may increase the risk of urinary tract infections or genital infections, so should any symptoms of infection arise, prompt consultation with healthcare professionals is advised. Women who are pregnant or planning to become pregnant should avoid using this medication, and breastfeeding mothers should also avoid it. Elderly patients are at higher risk of decreased kidney function, and therefore need to be monitored more closely when using this medication. Gastrointestinal disturbances (nausea, vomiting, diarrhea, etc.) may occur during treatment; these symptoms commonly happen early in treatment but should be reported to healthcare professionals if severe. This medication may interact with other drugs; hence, if other medications are being taken, it is essential to inform healthcare professionals, especially when taking drugs that may affect kidney function. If undergoing surgery or tests using iodine contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. This medication should not be crushed or chewed but swallowed whole, and weight changes should be monitored periodically as weight loss may occur. In case of overdose, contact healthcare professionals immediately and receive appropriate treatment based on the symptoms.
Severe acidosis, hypoglycemia, symptomatic hypotension, acute kidney injury, increased serum creatinine, decreased kidney function, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, vaginal infection, cystitis, pyelonephritis, arthralgia, back pain, contusion, ligament rupture, ligament sprain, wrist fracture, sting by arthropods, tendinitis, muscle strain, headache, dizziness, frictional urticaria, dyslipidemia, hyperlipidemia, genital pruritus, genital erythema, dysuria, nocturia, polyuria, cardiac hypertrophy, worsening condition, cough, respiratory distress, increased aspartate aminotransferase, increased alanine aminotransferase, anemia, bone marrow suppression, hypertension, orthostatic hypotension, insomnia, anxiety, subacute thyroiditis, dyspepsia, constipation, gastritis, epigastric pain, abdominal pain, diarrhea, dry mouth, small intestine colitis, passage of bloody stools, vaginal infection, nasopharyngitis, periodontitis, cystitis, latent tuberculosis, upper respiratory infection, anal abscess, folliculitis, pyelonephritis, tinea, arthralgia, back pain, intervertebral disc degeneration of the spine, spinal osteoarthritis, cervical stenosis, groin pain, musculoskeletal chest pain, headache, dizziness, sensory disturbance, frictional urticaria, dyslipidemia, hyperlipidemia, benign prostatic hyperplasia, genital pruritus, genital erythema, dysuria, nocturia, polyuria, cardiac hypertrophy, worsening condition, cough, respiratory distress, increased aspartate aminotransferase, increased alanine aminotransferase, anemia, bone marrow suppression, hypertension, orthostatic hypotension, insomnia, anxiety, subacute thyroiditis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is important to maintain a cool room temperature between 1 degree and 30 degrees Celsius for storage. Doing so will help maintain the effectiveness and ensure safe use of the medication.
White and light pink oval-shaped extended-release bilayer tablet
30 tablets/bottle, 300 tablets/bottle, 28 tablets/box [(7 tablets/PTP) X 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEnavogliflozin 0.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEnavogliflozin 0.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hanol BioPharma Co., Ltd.
CombinationEnavogliflozin 0.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.